Allarity Therapeutics Inc (ALLR) concluded trading on Wednesday at a closing price of $1.14, with 3.82 million shares of worth about $4.35 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -49.11% during that period and on March 26, 2025 the price saw a gain of about 2.70%. Currently the company’s common shares owned by public are about 4.43M shares, out of which, 3.39M shares are available for trading.
Stock saw a price change of 14.00% in past 5 days and over the past one month there was a price change of 61.70%. Year-to-date (YTD), ALLR shares are showing a performance of -2.56% which decreased to -99.46% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.68 but also hit the highest price of $199.62 during that period. The average intraday trading volume for Allarity Therapeutics Inc shares is 2.76 million. The stock is currently trading 16.16% above its 20-day simple moving average (SMA20), while that difference is up 10.29% for SMA50 and it goes to -63.27% lower than SMA200.
Allarity Therapeutics Inc (NASDAQ: ALLR) currently have 4.43M outstanding shares and institutions hold larger chunk of about 2.36% of that.
The stock has a current market capitalization of $5.05M and its 3Y-monthly beta is at -0.02. It has posted earnings per share of -$883.45 in the same period. It has Quick Ratio of 2.75 while making debt-to-equity ratio of 0.10. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ALLR, volatility over the week remained 13.38% while standing at 15.31% over the month.
